With its bioceramic platforms, Emplicure develops products at the interface between pharmacy and materials science, enabling high-precision drug delivery.  But not only that, the technology can also be applied to consumer products and the company already has several lines of business. BioStock contacted CEO Torbjörn W. Larsson to find out more about the synergies that the platforms bring with them and what this means for the company's business strategy.

Read the full interview with Emplicure's CEO Torbjörn W. Larsson at biostock.se:

https://www.biostock.se/en/2022/03/emplicures-ceo-on-the-strength-of-their-business-model/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

https://news.cision.com/emplicure-ab/r/biostock-emplicure-s-ceo-on-the-strength-of-their-business-model,c3536606

(c) 2022 Cision. All rights reserved., source Press Releases - English